skip to Main Content

BeHRA and FibriCheck join forces for Heart Rhythm Week

On the occasion of Heart Rhythm Week, the Belgian Heart Rhythm Association (BeHRA) in association with FibriCheck is organising a nationwide campaign to raise awareness of remote heart rhythm monitoring for 10,000 people who are at risk.

FibriCheck brings TGA-certified heart health app to Australia

FibriCheck, the app capable of detecting heart rhythm disorders like atrial fibrillation, is now available in Australia for use with compatible smartphones (both iPhone and Android) as well as selected smartwatches. This means that the more than 500.000 Australians at…

9 million euros in funding for eHealth pioneer Qompium

Hasselt, February 3, 2021 - Qompium, the pioneering Belgian digital health company, has received an additional 9 million euros in funding after a new capital round. With its business units FibriCheck (medical app which detects heart rhythm disorders) and Extra Horizon (secure,…

Safeguarding continuity of care in the UK during the pandemic

As TeleCheck AF continues to gain traction across the continent, notable strides are being made in the UK, where recently published guidelines cite FibriCheck’s remote heart rhythm monitoring as an example of clinical best practice in the delivery of care for cardiovascular disease…

2020: a year of challenges and triumphs for FibriCheck

It’s been an exciting year for FibriCheck! And looking back at everything we achieved together with our partners in 2020, it’s remarkable how many milestones we have reached and surpassed. Read on for a brief overview of the year that…

CE approval for revolutionary (semi-)continuous monitoring technology

People suffering from potential heart rhythm disorders will soon be able to sleep a little easier. Because FibriCheck’s (semi-)continuous heart rhythm monitoring technology was recently granted CE approval by the European authorities. This is a major leap forward towards a future where users…

First step towards the Asia-Pacific region

FibriCheck gains approval from Australia’s Therapeutic Goods Administration (TGA) FibriCheck, the mobile app capable of detecting heart rhythm disorders, was granted an Australian Register of Therapeutic Goods Certificate by the Australian Government Department of Health last week. As the first…

FibriCheck guards you while you sleep

Night monitoring now closer than ever after successful beta test If you’re familiar with atrial fibrillation, you’ll know it can be a dangerous condition – the heart rhythm disorder is responsible for around 25% of all strokes1. You’ll also know…

Back To Top
Search